• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. PULSE GEN MODEL 103; GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. PULSE GEN MODEL 103; GENERATOR Back to Search Results
Model Number 103
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Asystole (4442)
Event Date 04/18/2023
Event Type  Death  
Manufacturer Narrative
Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any defects¿ or malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
 
Event Description
It was reported that the patient was in the hospital and had atrial fibrillation.A cardioversion was performed without consulting vns precautions.Following the cardioversion, the patient became bradycardic and hypotensive, and complained of neck and jaw pain.Narcan was administered, and the patient¿s blood pressure improved.Twenty minutes later, the patient started to deteriorate again, and was transferred to the intensive care unit (icu).The patient was put on vasopressors and was stable.Hours later, the patient deteriorated again.Since they were do not resuscitate (dnr), cpr was not performed, but epinephrine was administered, improving their pulse.The patient passed away minutes later.Since this occurred within 12 hours of having a cardioversion, it was determined an unexpected death.The patient¿s physician later reported that the cause of neck and jaw pain was related to the presence of vns.The patient had a palpable muscle spasm along the left sternocleidomastoid (scm) muscle after their cardioversion in the icu.The hypotension was not related to vns but related to the sedation, cardiovascular medications, and patient¿s anemia.The atrial fibrillation was present on admission on 3/23, 3/28, and (b)(6) 2023.The last occurrence was post mechanical fall.The bradycardia was related to the amiodarone plus medication.The physician notes the cause of death was asystole.The patient was ¿do not resuscitate (dnr) so no attempts at transcutaneous or transvenous temp pacing were performed.The physician could not say for sure whether the death was related to vns since the patient had both acute and chronic respiratory and cardiovascular conditions that increases her risk.They cannot exclude vns as a contributing factor after the cardioversion.No other relevant information has been received to date.
 
Event Description
It was later reported that the initial reporter also submitted a report to the fda.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSE GEN MODEL 103
Type of Device
GENERATOR
Manufacturer (Section D)
LIVANOVA USA, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
LIVANOVA USA, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
dana sprague
100 cyberonics blvd
suite 600
houston, TX 77058
2816672681
MDR Report Key16963214
MDR Text Key315580521
Report Number1644487-2023-00643
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/18/2013
Device Model Number103
Device Lot Number3213
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Event Location Other
Date Manufacturer Received07/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/19/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age74 YR
Patient SexFemale
-
-